Connect Biopharma Holdings Ltd
Connect Biopharma Holdings Ltd
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||
Assets Current | ||||||||||||
Cash And Cash Equivalents At Carrying Value | 27 | 46 | 38 | 38 | 41 | 48 | 78 | |||||
Short Term Investments | 4 | 0 | 6 | 17 | 31 | 36 | 15 | |||||
Accounts Receivable Net Current | 3 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense And Other Assets Current | 4 | 9 | 7 | 8 | 6 | 4 | 2 | |||||
Assets Current | 39 | 55 | 51 | 63 | 78 | 88 | 97 | |||||
Property Plant And Equipment Net | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |||||
Assets | 43 | 60 | 56 | 67 | 83 | 93 | 101 | |||||
Liabilities And Stockhold… | ||||||||||||
Liabilities Current | ||||||||||||
Accounts Payable Current | 2 | 4 | 2 | 2 | 2 | 1 | 0 | |||||
Accrued Liabilities Current | 14 | 12 | 11 | 9 | 8 | 7 | 8 | |||||
Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 16 | 17 | 14 | 11 | 11 | 9 | 8 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Contract With Customer Liability Noncurrent | - | - | - | - | - | - | 1 | |||||
Liabilities | 17 | 17 | 14 | 12 | 11 | 10 | 9 | |||||
Stockholders Equity | ||||||||||||
Preferred Stock Value | - | - | 0 | - | - | - | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 466 | 464 | 444 | 443 | 441 | 440 | 439 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -1 | -1 | -1 | -1 | -2 | -2 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -438 | -420 | -401 | -386 | -369 | -356 | -345 | |||||
Stockholders Equity | 27 | 43 | 42 | 55 | 71 | 83 | 92 | |||||
Liabilities And Stockholders Equity | 43 | 60 | 56 | 67 | 83 | 93 | 101 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | 0 | - | - | - | 0 | |||||
Preferred Stock Shares Authorized | - | - | 40 | - | - | - | 40 | |||||
Preferred Stock Shares Issued | - | - | 0 | - | - | - | 0 | |||||
Preferred Stock Shares Outstanding | - | - | 0 | - | - | - | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | 400 | |||||
Common Stock Shares Issued | 63 | 63 | 56 | 56 | 56 | 55 | 55 | |||||
Shares Outstanding | 63 | 63 | 56 | 56 | 56 | 55 | 55 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.03% | -8.21% | -22.01% | - | - | - | - | - | - | - | - | - |
| 2025 | 8.94% | 60.80% | 175.10% | -25.85% | -36.86% | -27.54% | 49.07% | 56.52% | 49.07% | -3.82% | -10.31% | -23.66% |
| 2024 | - | - | - | - | - | - | - | - | - | 42.00% | 37.27% | 87.27% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Connect Biopharma Holdings Ltd (CNTB) — SEC Financial Statements & Analysis
Connect Biopharma Holdings Ltd (CNTB) is a pharmaceutical preparations company, incorporated in E9. Connect Biopharma Holdings Ltd trades on Nasdaq as: CNTB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Connect Biopharma Holdings Ltd reported a Debt-to-Equity ratio of 0.62x, a Price-to-Sales (P/S) ratio of 50.68x (TTM), a Price-to-Book (P/B) ratio of 5.57x (TTM), at a market cap of $149.66M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.62x
- P/S TTM
- 50.68x
- P/B TTM
- 5.57x
- Market Cap
- $149.66M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Connect Biopharma Holdings Ltd in?
Connect Biopharma Holdings Ltd (CNTB) operates in the Pharmaceutical Preparations industry.
What is CNTB's market cap?
Connect Biopharma Holdings Ltd (CNTB) has a market capitalization of $149.66M as of 2026-06-30.
What exchange does CNTB trade on?
Connect Biopharma Holdings Ltd (CNTB) trades on the Nasdaq.
Where is Connect Biopharma Holdings Ltd incorporated?
Connect Biopharma Holdings Ltd is incorporated in Cayman Islands.